Genetic Associations of Plasminogen Activator Inhibitor-1-Related miRNA Variants with Coronary Artery Disease
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252111528 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yong Hyun Ha und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, College of Life Science, CHA University, Seongnam 13488, Republic of Korea. Hauptthemen laut MEDLINE: MicroRNAs, Coronary Artery Disease, Plasminogen Activator Inhibitor 1, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NFR, Korean government.
Abstract (Originalsprache)
Coronary artery disease (CAD) is one of the most common types of cardiovascular disease and can lead to a heart attack as plaque gradually builds up inside the coronary arteries, blocking blood flow. Previous studies have shown that polymorphisms in the PAI-1 gene are associated with CAD; however, studies of the PAI-1 3′-untranslated region, containing a miRNA binding site, and the miRNAs that interact with it, are insufficient. To investigate the association between miRNA polymorphisms and CAD in the Korean population based on post-transcriptional regulation, we genotyped five polymorphisms in four miRNAs targeting the 3′-untranslated region of PAI-1 using real-time PCR and TaqMan assays. We found that the mutant genotype of miR-30c rs928508 A > G was strongly associated with increased CAD susceptibility. In a genotype combination analysis, the combination of the homozygous mutant genotype (GG) of miR-30c rs928508 with the wild-type genotype (GG) of miR-143 rs41291957 resulted in increased risk for CAD. Also, in an allele combination analysis, the combination of the mutant allele (G) of miR-30c rs928508 and the wild-type allele (G) of miR-143 rs41291957 resulted in increased risk for CAD. Furthermore, metabolic syndrome and diabetes mellitus showed synergistic effects on CAD risk when combined with miR-30c rs928508. These results can be applied to identify CAD prognostic biomarkers among miRNA polymorphisms and various clinical factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science, College of Life Science, CHA University, Seongnam 13488, Republic of Korea.
- CHA Bundang Medical Center, Department of Cardiology, CHA University, Seongnam 13496, Republic of Korea.
- CHA Bundang Medical Center, Department of Neurology, CHA University, Seongnam 13496, Republic of Korea.
ORCID-Profile: Jung Hoon Sung, Ok Joon Kim, Nam Keun Kim
Förderung
- NFR
- Korean government
Zitieren
APA
Ha, Y. H., Sung, J. H., Ryu, C. S., Ko, E. J., Park, H. W., Park, H. S., Kim, O. J., Kim, I. J., & Kim, N. K. (2024). Genetic Associations of Plasminogen Activator Inhibitor-1-Related miRNA Variants with Coronary Artery Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111528
Vancouver
Ha YH, Sung JH, Ryu CS, Ko EJ, Park HW, Park HS, et al. Genetic Associations of Plasminogen Activator Inhibitor-1-Related miRNA Variants with Coronary Artery Disease. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111528
BibTeX
@article{Ha2024,
author = {Ha, Yong Hyun and Sung, Jung Hoon and Ryu, Chang Soo and Ko, Eun Ju and Park, Hyeon Woo and Park, Han Sung and Kim, Ok Joon and Kim, In Jai and Kim, Nam Keun},
title = {Genetic Associations of Plasminogen Activator Inhibitor-1-Related miRNA Variants with Coronary Artery Disease},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252111528}
}
EUVIMED